share_log

TD Cowen Initiates Coverage On Viridian Therapeutics With Buy Rating

TD Cowen Initiates Coverage On Viridian Therapeutics With Buy Rating

道明证券启动Virdian Therapeutics的买入评级
Benzinga ·  2024/11/25 19:09

TD Cowen analyst Joseph Thome initiates coverage on Viridian Therapeutics (NASDAQ:VRDN) with a Buy rating.

TD Cowen 分析师约瑟夫·托梅对维里迪安治疗公司(纳斯达克:VRDN)启动覆盖,并给予买入评级。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发